TY  - GEN
AU  - Walker,S
AU  - Burch,J
AU  - McKenna,C
AU  - Wright,K
AU  - Griffin,S
AU  - Woolacott,N
TI  - Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years
SN  - 2046-4924
PY  - 2012///0705
KW  - Anti-Asthmatic Agents
KW  - administration & dosage
KW  - Antibodies, Anti-Idiotypic
KW  - Antibodies, Monoclonal, Humanized
KW  - Asthma
KW  - drug therapy
KW  - Child
KW  - Cost-Benefit Analysis
KW  - Drug Therapy, Combination
KW  - Glucocorticoids
KW  - therapeutic use
KW  - Humans
KW  - Models, Economic
KW  - Multicenter Studies as Topic
KW  - Omalizumab
KW  - Quality of Life
KW  - Quality-Adjusted Life Years
KW  - Randomized Controlled Trials as Topic
KW  - Severity of Illness Index
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.3310/hta15suppl1/02
ER  -